TABLE 2.
MEANS OF THE COHORT CHARACTERISTICS BY QUARTILE OF NTproBNP
| Characteristic | VISIT 3 NT-proBNP | p-value | |||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||
| Age (years) | 59.4 | 62.3 | 66.3 | 71.1 | < 0.01 |
| Sex (male) | 69.6 | 51.2 | 46.0 | 40.0 | < 0.01 |
| Waist circumference (cm)* | 97.7 | 97.0 | 96.6 | 95.9 | 0.45 |
| Hip circumference (cm)* | 103.5 | 102.7 | 102.6 | 102.5 | 0.60 |
| BMI (kg/m2)* | 28.0 | 27.5 | 27.4 | 27.2 | 0.19 |
| Waist to Hip Ratio* | 0.9 | 0.9 | 0.9 | 0.9 | 0.40 |
| Visceral Fat Area (cm2)* | 147 | 144 | 149 | 140 | 0.25 |
| Subcutaneous Fat Area (cm2)* | 250 | 238 | 243 | 234 | 0.34 |
| Dyslipidemia (Y/N)* | 38.9 | 36.3 | 37.7 | 36.7 | 0.90 |
| Triglycerides (mg/dl)* | 136.3 | 140.6 | 133.2 | 133.6 | 0.75 |
| Glucose (mg/dl)* | 97.0 | 100.5 | 97.4 | 97.2 | 0.22 |
| Diabetes (Y/N)* | 12.7 | 13.2 | 12.9 | 18.0 | 0.18 |
| Ever Smoker* | 50.1 | 46.8 | 52.5 | 50.7 | 0.46 |
| Systolic Blood Pressure (mmHg)* | 120.4 | 123.3 | 126.0 | 129.6 | < 0.01 |
| Diastolic Blood Pressure (mmHg)* | 68.9 | 68.9 | 69.5 | 69.7 | 0.71 |
| Hypertension (Y/N)* | 41.0 | 45.8 | 49.9 | 63.3 | < 0.01 |
| eGFR by CKD Epi (ml/min/1.73 m2)* | 79.3 | 79.5 | 78.9 | 76.2 | 0.03 |
| CKD (eGFR < 60)* | 15.3 | 16.4 | 17.7 | 21.6 | 0.12 |
| Adiponectin (μg/ml)* | 16.5 | 18.3 | 20.2 | 24.0 | < 0.01 |
| Leptin (ng/ml)* | 20.8 | 20.0 | 20.3 | 19.5 | 0.88 |
| Aldosterone (pg/ml)* | 152.6 | 142.2 | 153.6 | 150.4 | 0.32 |
| Renin (ng/ml)* | 1.6 | 1.4 | 1.0 | 1.1 | 0.11 |
| End-Diastolic LV Mass (g)* | 139.3 | 139.8 | 142.8 | 152.9 | < 0.01 |
| LV Ejection Fraction (%)* | 70.1 | 70.2 | 69.9 | 68.6 | 0.06 |
Q1 = Quartile 1 (< 34.4 pg/ml), Q2 = Quartile 2 (34.4 – 66.7 pg/ml), Q3 = Quartile 3 (66.7 – 130.1 pg/ml), Q4 = Quartile 4 (> 130.1 pg/ml)
*
Adjusted for age, sex and race.